25 XP   0   0   10

Incyte Corporation
Buy, Hold or Sell?

Let's analyse Incyte together

PenkeI guess you are interested in Incyte Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Incyte Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Incyte Corporation

I send you an email if I find something interesting about Incyte Corporation.

Quick analysis of Incyte (30 sec.)










What can you expect buying and holding a share of Incyte? (30 sec.)

How much money do you get?

How much money do you get?
$0.12
When do you have the money?
1 year
How often do you get paid?
12.5%

What is your share worth?

Current worth
$22.95
Expected worth in 1 year
$26.47
How sure are you?
85.0%

+ What do you gain per year?

Total Gains per Share
$3.64
Return On Investment
7.1%

For what price can you sell your share?

Current Price per Share
$51.18
Expected price per share
$50.27 - $56.10
How sure are you?
50%

1. Valuation of Incyte (5 min.)




Live pricePrice per Share (EOD)

$51.18

Intrinsic Value Per Share

$18.26 - $46.54

Total Value Per Share

$41.21 - $69.49

2. Growth of Incyte (5 min.)




Is Incyte growing?

Current yearPrevious yearGrowGrow %
How rich?$5.1b$4.1b$694.9m14.4%

How much money is Incyte making?

Current yearPrevious yearGrowGrow %
Making money$149.3m$85.1m$64.2m43.0%
Net Profit Margin15.6%9.9%--

How much money comes from the company's main activities?

3. Financial Health of Incyte (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#13 / 1010

Most Revenue
#21 / 1010

Most Profit
#24 / 1010

Most Efficient
#92 / 1010

What can you expect buying and holding a share of Incyte? (5 min.)

Welcome investor! Incyte's management wants to use your money to grow the business. In return you get a share of Incyte.

What can you expect buying and holding a share of Incyte?

First you should know what it really means to hold a share of Incyte. And how you can make/lose money.

Speculation

The Price per Share of Incyte is $51.18. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Incyte.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Incyte, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $22.95. Based on the TTM, the Book Value Change Per Share is $0.88 per quarter. Based on the YOY, the Book Value Change Per Share is $0.66 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.03 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Incyte.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.891.7%0.661.3%0.380.7%0.450.9%0.210.4%
Usd Book Value Change Per Share1.152.2%0.881.7%0.661.3%0.721.4%0.571.1%
Usd Dividend Per Share0.000.0%0.030.1%0.020.0%0.010.0%0.010.0%
Usd Total Gains Per Share1.152.2%0.911.8%0.681.3%0.731.4%0.581.1%
Usd Price Per Share62.79-63.77-75.59-77.57-82.48-
Price to Earnings Ratio17.65-60.44-83.89-30.37-35.79-
Price-to-Total Gains Ratio54.76-92.85-123.11-110.64--47.21-
Price to Book Ratio2.74-3.00-4.12-5.87-15.86-
Price-to-Total Gains Ratio54.76-92.85-123.11-110.64--47.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share51.18
Number of shares19
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.01
Usd Book Value Change Per Share0.880.72
Usd Total Gains Per Share0.910.73
Gains per Quarter (19 shares)17.2813.85
Gains per Year (19 shares)69.1455.42
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12675915545
251341282109100
372001972164155
492672663218210
5123343354273265
6144014045328320
7174674736382375
8195345426437430
9216016117492485
10246686808546540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%18.02.00.090.0%29.011.00.072.5%41.080.00.033.9%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%34.05.01.085.0%62.056.03.051.2%
Dividend per Share3.00.01.075.0%5.00.07.041.7%5.00.015.025.0%5.00.035.012.5%5.00.0116.04.1%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%34.05.01.085.0%62.056.03.051.2%

Fundamentals of Incyte

About Incyte Corporation

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States and internationally. The company offers JAKAFI (ruxolitinib) for treatment of intermediate or high-risk myelofibrosis, polycythemia vera, and steroid-refractory acute graft-versus-host disease; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab) for relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in liquid and solid tumor types; ICLUSIG (ponatinib) to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; and ZYNYZ (retifanlimab-dlwr) to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma, as well as OPZELURA cream for treatment of atopic dermatitis. Its clinical stage products include retifanlimab under Phase 3 clinical trials for squamous cell carcinoma of the anal canal and non-small cell lung cancer; axatilimab, an anti-CSF-1R monoclonal antibody under Phase 2 that is being developed as a therapy for patients with chronic GVHD; INCA033989 to inhibit oncogenesis; INCB160058, which is being developed as a disease-modifying therapeutic; and INCB99280 and INCB99318 for the treatment solid tumors. The company also develops INCB123667, INCA32459, and INCA33890, as well as Ruxolitinib cream, Povorcitinib, and INCA034460. It has collaboration out-license agreements with Novartis and Lilly; in-license agreements with Agenus, Merus, MacroGenics, and Syndax; and collaboration and license agreement with China Medical System Holdings Limited for the development and commercialization of povorcitinib. The company sells its products to specialty, retail, and hospital pharmacies, distributors, and wholesalers. The company was formerly known as Incyte Genomics Inc and changed its name to Incyte Corporation in March 2003. Incyte Corporation

Fundamental data was last updated by Penke on 2024-04-11 11:48:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Incyte Corporation.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Incyte earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Incyte to the Biotechnology industry mean.
  • A Net Profit Margin of 19.8% means that $0.20 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Incyte Corporation:

  • The MRQ is 19.8%. The company is making a huge profit. +2
  • The TTM is 15.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ19.8%TTM15.6%+4.2%
TTM15.6%YOY9.9%+5.7%
TTM15.6%5Y11.7%+3.9%
5Y11.7%10Y3.4%+8.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ19.8%-207.2%+227.0%
TTM15.6%-216.8%+232.4%
YOY9.9%-282.3%+292.2%
5Y11.7%-436.8%+448.5%
10Y3.4%-597.3%+600.7%
1.1.2. Return on Assets

Shows how efficient Incyte is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Incyte to the Biotechnology industry mean.
  • 3.0% Return on Assets means that Incyte generated $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Incyte Corporation:

  • The MRQ is 3.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.0%TTM2.3%+0.6%
TTM2.3%YOY1.6%+0.7%
TTM2.3%5Y1.9%+0.4%
5Y1.9%10Y0.6%+1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0%-13.3%+16.3%
TTM2.3%-12.8%+15.1%
YOY1.6%-11.6%+13.2%
5Y1.9%-13.8%+15.7%
10Y0.6%-15.6%+16.2%
1.1.3. Return on Equity

Shows how efficient Incyte is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Incyte to the Biotechnology industry mean.
  • 3.9% Return on Equity means Incyte generated $0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Incyte Corporation:

  • The MRQ is 3.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.9%TTM3.0%+0.8%
TTM3.0%YOY2.1%+1.0%
TTM3.0%5Y2.4%+0.7%
5Y2.4%10Y1.6%+0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9%-16.9%+20.8%
TTM3.0%-16.1%+19.1%
YOY2.1%-14.9%+17.0%
5Y2.4%-19.3%+21.7%
10Y1.6%-20.1%+21.7%

1.2. Operating Efficiency of Incyte Corporation.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Incyte is operating .

  • Measures how much profit Incyte makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Incyte to the Biotechnology industry mean.
  • An Operating Margin of 24.9% means the company generated $0.25  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Incyte Corporation:

  • The MRQ is 24.9%. The company is operating efficient. +1
  • The TTM is 21.3%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ24.9%TTM21.3%+3.7%
TTM21.3%YOY17.3%+4.0%
TTM21.3%5Y12.8%+8.5%
5Y12.8%10Y6.2%+6.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ24.9%-298.0%+322.9%
TTM21.3%-238.5%+259.8%
YOY17.3%-288.4%+305.7%
5Y12.8%-486.2%+499.0%
10Y6.2%-628.4%+634.6%
1.2.2. Operating Ratio

Measures how efficient Incyte is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.80 means that the operating costs are $0.80 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Incyte Corporation:

  • The MRQ is 0.800. The company is less efficient in keeping operating costs low.
  • The TTM is 0.829. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.800TTM0.829-0.029
TTM0.829YOY0.827+0.003
TTM0.8295Y0.881-0.052
5Y0.88110Y0.938-0.057
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8003.235-2.435
TTM0.8293.310-2.481
YOY0.8273.838-3.011
5Y0.8815.679-4.798
10Y0.9387.823-6.885

1.3. Liquidity of Incyte Corporation.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Incyte is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.75 means the company has $3.75 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Incyte Corporation:

  • The MRQ is 3.745. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.787. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.745TTM3.787-0.042
TTM3.787YOY3.687+0.100
TTM3.7875Y4.029-0.242
5Y4.02910Y3.919+0.109
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7453.863-0.118
TTM3.7874.169-0.382
YOY3.6875.337-1.650
5Y4.0296.122-2.093
10Y3.9196.434-2.515
1.3.2. Quick Ratio

Measures if Incyte is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Incyte to the Biotechnology industry mean.
  • A Quick Ratio of 3.90 means the company can pay off $3.90 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Incyte Corporation:

  • The MRQ is 3.904. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.794. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.904TTM3.794+0.110
TTM3.794YOY3.707+0.086
TTM3.7945Y4.226-0.432
5Y4.22610Y4.278-0.052
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9043.504+0.400
TTM3.7943.991-0.197
YOY3.7075.371-1.664
5Y4.2266.088-1.862
10Y4.2786.395-2.117

1.4. Solvency of Incyte Corporation.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Incyte assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Incyte to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.23 means that Incyte assets are financed with 23.5% credit (debt) and the remaining percentage (100% - 23.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Incyte Corporation:

  • The MRQ is 0.235. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.232. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.235TTM0.232+0.002
TTM0.232YOY0.238-0.006
TTM0.2325Y0.247-0.015
5Y0.24710Y0.464-0.217
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2350.339-0.104
TTM0.2320.337-0.105
YOY0.2380.271-0.033
5Y0.2470.368-0.121
10Y0.4640.388+0.076
1.4.2. Debt to Equity Ratio

Measures if Incyte is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Incyte to the Biotechnology industry mean.
  • A Debt to Equity ratio of 30.7% means that company has $0.31 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Incyte Corporation:

  • The MRQ is 0.307. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.303. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.307TTM0.303+0.004
TTM0.303YOY0.313-0.010
TTM0.3035Y0.330-0.027
5Y0.33010Y1.353-1.024
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3070.392-0.085
TTM0.3030.403-0.100
YOY0.3130.335-0.022
5Y0.3300.427-0.097
10Y1.3530.461+0.892

2. Market Valuation of Incyte Corporation

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Incyte generates.

  • Above 15 is considered overpriced but always compare Incyte to the Biotechnology industry mean.
  • A PE ratio of 17.65 means the investor is paying $17.65 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Incyte Corporation:

  • The EOD is 14.389. Based on the earnings, the company is underpriced. +1
  • The MRQ is 17.653. Based on the earnings, the company is fair priced.
  • The TTM is 60.444. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD14.389MRQ17.653-3.264
MRQ17.653TTM60.444-42.792
TTM60.444YOY83.889-23.444
TTM60.4445Y30.372+30.072
5Y30.37210Y35.787-5.415
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD14.389-2.300+16.689
MRQ17.653-2.656+20.309
TTM60.444-2.718+63.162
YOY83.889-4.145+88.034
5Y30.372-6.258+36.630
10Y35.787-6.315+42.102
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Incyte Corporation:

  • The EOD is 19.890. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 24.402. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 7.312. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD19.890MRQ24.402-4.512
MRQ24.402TTM7.312+17.090
TTM7.312YOY19.955-12.644
TTM7.3125Y27.029-19.717
5Y27.02910Y18.857+8.171
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD19.890-2.974+22.864
MRQ24.402-3.306+27.708
TTM7.312-3.508+10.820
YOY19.955-5.613+25.568
5Y27.029-8.378+35.407
10Y18.857-8.873+27.730
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Incyte is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.74 means the investor is paying $2.74 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Incyte Corporation:

  • The EOD is 2.230. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.736. Based on the equity, the company is underpriced. +1
  • The TTM is 3.000. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.230MRQ2.736-0.506
MRQ2.736TTM3.000-0.265
TTM3.000YOY4.116-1.116
TTM3.0005Y5.869-2.869
5Y5.86910Y15.861-9.992
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.2301.914+0.316
MRQ2.7362.116+0.620
TTM3.0002.097+0.903
YOY4.1162.881+1.235
5Y5.8693.550+2.319
10Y15.8613.936+11.925
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Incyte Corporation.

3.1. Institutions holding Incyte Corporation

Institutions are holding 100.218% of the shares of Incyte Corporation.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Baker Bros Advisors LP16.130725.8481361791225560.0015
2023-12-31BlackRock Inc10.83350.038924298022520530.2147
2023-12-31Vanguard Group Inc10.04040.0309225193813599621.6244
2023-12-31Dodge & Cox7.1740.641316090421-325690-1.984
2023-12-31State Street Corporation4.51220.0309101201706091406.4046
2023-12-31Renaissance Technologies Corp2.47630.5398555393775740415.7907
2023-12-31Geode Capital Management, LLC1.90530.02842734481059542.5424
2023-12-31Morgan Stanley - Brokerage Accounts1.49620.01863355698123596058.3072
2023-12-31Amundi1.3610.08853052505116170961.4402
2023-12-31Acadian Asset Management LLC1.34480.7343301623933161812.3525
2023-12-31Amvescap Plc.1.220.04092736322-1185723-30.2323
2023-12-31LSV Asset Management1.20020.368826918271465792119.5555
2023-12-31Man Group PLC1.05960.41552376434-155184-6.1298
2023-12-31Goldman Sachs Group Inc1.05090.013323570521812628.3309
2023-12-31Pictet Asset Manangement SA1.04160.16182336246215800.9323
2023-12-31Bellevue Group AG0.96162.07152156719-334731-13.4352
2023-09-30Jacobs Levy Equity Management, Inc.0.92980.7136208546531373117.7076
2023-12-31Northern Trust Corp0.88350.02251981495-146193-6.871
2023-12-31NORGES BANK0.87520.0215196293740456125.9604
2023-12-31Legal & General Group PLC0.87210.0315195594921902512.6099
Total 67.368931.8602151099389+5072786+3.4%

3.2. Funds holding Incyte Corporation

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Dodge & Cox Stock I4.51950.630510136628-170266-1.652
2024-02-29Vanguard Total Stock Mkt Idx Inv2.65710.02245959622-14158-0.237
2024-02-29Vanguard Institutional 500 Index Trust2.06950.02534641658427810.9302
2024-02-29Vanguard Mid Cap Index Institutional1.89790.15514256745-12534-0.2936
2023-09-30BB Biotech AG Ord1.1085.87342485050-131950-5.042
2024-03-28SPDR® S&P 500 ETF Trust1.00870.0242262477132000.5869
2024-02-29Fidelity 500 Index0.99470.02532230908224481.0165
2024-03-28iShares MSCI USA Min Vol Factor ETF0.94310.4898211531100
2024-03-28iShares Core S&P 500 ETF0.85980.0241928408142080.7422
2024-03-28Invesco S&P 500® Equal Weight ETF0.78890.185176938944000.2493
2024-02-29Vanguard Growth Index Investor0.78890.04651769305132500.7545
2024-03-28iShares Biotechnology ETF0.74241.2431665014-2897-0.1737
2024-03-28Health Care Select Sector SPDR® ETF0.62290.19281397085-2259-0.1614
2024-02-29Vanguard Mid-Cap Growth ETF0.60930.3297136654380960.596
2023-12-31Dodge & Cox Balanced Composite0.58270.58121307000-7300-0.5554
2023-12-31Dodge & Cox Balanced I0.58270.58351307000-7300-0.5554
2024-03-28SPDR® S&P Biotech ETF0.56760.96041272975160401.2761
2024-02-29Vanguard Institutional Index I0.54630.02531225320-7149-0.5801
2023-12-31Dodge & Cox Global Stock I0.50970.65911143280-41200-3.4783
2024-02-29State St S&P 500® Indx SL Cl III0.40140.025290025157000.6372
Total 22.801112.101551139969-256890-0.5%

3.3. Insider Transactions

Insiders are holding 1.579% of the shares of Incyte Corporation.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-02Vijay K IyengarSELL65765
2023-12-12Thomas TraySELL21057.36

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Incyte Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.1470.879+31%0.661+73%0.719+60%0.574+100%
Book Value Per Share--22.95121.387+7%18.415+25%14.913+54%8.993+155%
Current Ratio--3.7453.787-1%3.687+2%4.029-7%3.919-4%
Debt To Asset Ratio--0.2350.232+1%0.238-1%0.247-5%0.464-49%
Debt To Equity Ratio--0.3070.303+1%0.313-2%0.330-7%1.353-77%
Dividend Per Share---0.031-100%0.022-100%0.011-100%0.005-100%
Eps--0.8890.661+34%0.379+134%0.453+96%0.211+322%
Free Cash Flow Per Share--0.6430.497+30%0.993-35%0.492+31%0.280+130%
Free Cash Flow To Equity Per Share--0.6450.475+36%0.992-35%0.515+25%0.396+63%
Gross Profit Margin--1.0001.000+0%0.999+0%1.000+0%1.000+0%
Intrinsic Value_10Y_max--46.541--------
Intrinsic Value_10Y_min--18.260--------
Intrinsic Value_1Y_max--3.100--------
Intrinsic Value_1Y_min--1.248--------
Intrinsic Value_3Y_max--10.506--------
Intrinsic Value_3Y_min--4.275--------
Intrinsic Value_5Y_max--19.349--------
Intrinsic Value_5Y_min--7.856--------
Market Cap11491240680.000-24%14198388750.00014403505905.000-1%16977664145.000-16%17435400736.000-19%18528420069.500-23%
Net Profit Margin--0.1980.156+27%0.099+100%0.117+69%0.034+478%
Operating Margin--0.2490.213+17%0.173+44%0.128+95%0.062+301%
Operating Ratio--0.8000.829-3%0.827-3%0.881-9%0.938-15%
Pb Ratio2.230-23%2.7363.000-9%4.116-34%5.869-53%15.861-83%
Pe Ratio14.389-23%17.65360.444-71%83.889-79%30.372-42%35.787-51%
Price Per Share51.180-23%62.79063.770-2%75.588-17%77.573-19%82.482-24%
Price To Free Cash Flow Ratio19.890-23%24.4027.312+234%19.955+22%27.029-10%18.857+29%
Price To Total Gains Ratio44.631-23%54.75592.848-41%123.105-56%110.636-51%-47.210+186%
Quick Ratio--3.9043.794+3%3.707+5%4.226-8%4.278-9%
Return On Assets--0.0300.023+28%0.016+88%0.019+57%0.006+378%
Return On Equity--0.0390.030+28%0.021+88%0.024+63%0.016+141%
Total Gains Per Share--1.1470.910+26%0.683+68%0.729+57%0.579+98%
Usd Book Value--5189837000.0004831136000.000+7%4136225750.000+25%3354496500.000+55%2022205975.000+157%
Usd Book Value Change Per Share--1.1470.879+31%0.661+73%0.719+60%0.574+100%
Usd Book Value Per Share--22.95121.387+7%18.415+25%14.913+54%8.993+155%
Usd Dividend Per Share---0.031-100%0.022-100%0.011-100%0.005-100%
Usd Eps--0.8890.661+34%0.379+134%0.453+96%0.211+322%
Usd Free Cash Flow--145462000.000112250250.000+30%223027000.000-35%110669650.000+31%62888000.000+131%
Usd Free Cash Flow Per Share--0.6430.497+30%0.993-35%0.492+31%0.280+130%
Usd Free Cash Flow To Equity Per Share--0.6450.475+36%0.992-35%0.515+25%0.396+63%
Usd Market Cap11491240680.000-24%14198388750.00014403505905.000-1%16977664145.000-16%17435400736.000-19%18528420069.500-23%
Usd Price Per Share51.180-23%62.79063.770-2%75.588-17%77.573-19%82.482-24%
Usd Profit--201079000.000149399750.000+35%85165000.000+136%101902450.000+97%47416800.000+324%
Usd Revenue--1013341000.000923912250.000+10%848658750.000+19%745100600.000+36%517276875.000+96%
Usd Total Gains Per Share--1.1470.910+26%0.683+68%0.729+57%0.579+98%
 EOD+4 -4MRQTTM+26 -10YOY+24 -125Y+28 -810Y+28 -8

4.2. Fundamental Score

Let's check the fundamental score of Incyte Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1514.389
Price to Book Ratio (EOD)Between0-12.230
Net Profit Margin (MRQ)Greater than00.198
Operating Margin (MRQ)Greater than00.249
Quick Ratio (MRQ)Greater than13.904
Current Ratio (MRQ)Greater than13.745
Debt to Asset Ratio (MRQ)Less than10.235
Debt to Equity Ratio (MRQ)Less than10.307
Return on Equity (MRQ)Greater than0.150.039
Return on Assets (MRQ)Greater than0.050.030
Total7/10 (70.0%)

4.3. Technical Score

Let's check the technical score of Incyte Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5020.704
Ma 20Greater thanMa 5054.007
Ma 50Greater thanMa 10056.943
Ma 100Greater thanMa 20058.816
OpenGreater thanClose51.580
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Retained Earnings  -437,21421,703-415,511203,548-211,963171,269-40,694201,079160,385



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets6,782,107
Total Liabilities1,592,270
Total Stockholder Equity5,189,837
 As reported
Total Liabilities 1,592,270
Total Stockholder Equity+ 5,189,837
Total Assets = 6,782,107

Assets

Total Assets6,782,107
Total Current Assets4,645,402
Long-term Assets2,136,705
Total Current Assets
Cash And Cash Equivalents 3,213,376
Short-term Investments 442,667
Net Receivables 743,557
Inventory 62,972
Other Current Assets 182,830
Total Current Assets  (as reported)4,645,402
Total Current Assets  (calculated)4,645,402
+/-0
Long-term Assets
Property Plant Equipment 777,048
Goodwill 155,593
Long Term Investments 187,716
Intangible Assets 123,545
Long-term Assets Other 260,917
Long-term Assets  (as reported)2,136,705
Long-term Assets  (calculated)1,504,819
+/- 631,886

Liabilities & Shareholders' Equity

Total Current Liabilities1,240,379
Long-term Liabilities351,891
Total Stockholder Equity5,189,837
Total Current Liabilities
Short-term Debt 9,125
Accounts payable 109,601
Other Current Liabilities 111,747
Total Current Liabilities  (as reported)1,240,379
Total Current Liabilities  (calculated)230,473
+/- 1,009,906
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt29,162
Long-term Liabilities Other 322,729
Long-term Liabilities  (as reported)351,891
Long-term Liabilities  (calculated)351,891
+/-0
Total Stockholder Equity
Common Stock224
Retained Earnings 160,385
Accumulated Other Comprehensive Income 13,106
Other Stockholders Equity 5,016,122
Total Stockholder Equity (as reported)5,189,837
Total Stockholder Equity (calculated)5,189,837
+/-0
Other
Capital Stock224
Cash and Short Term Investments 3,656,043
Common Stock Shares Outstanding 226,125
Current Deferred Revenue1,009,906
Liabilities and Stockholders Equity 6,782,107
Net Debt -3,175,089
Net Invested Capital 5,189,837
Net Working Capital 3,405,023
Property Plant and Equipment Gross 1,046,982
Short Long Term Debt Total 38,287



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-30
> Total Assets 
3,400
17,600
15,300
13,300
19,100
28,700
26,700
23,000
20,000
57,800
62,100
66,000
74,400
66,900
79,600
76,600
181,100
193,100
219,100
219,200
233,000
230,300
250,800
224,200
209,700
221,900
875,692
876,635
865,924
886,820
886,820
852,068
825,640
705,559
705,559
645,736
603,054
552,139
496,878
470,475
415,437
379,545
582,468
538,118
470,504
516,919
487,458
436,647
398,109
374,108
398,756
375,112
464,886
353,603
324,933
308,798
282,683
275,695
237,011
204,735
264,718
232,388
189,635
159,016
472,816
712,390
502,663
493,681
464,640
489,581
459,606
416,663
371,224
328,962
293,593
311,971
296,535
330,419
330,282
334,219
357,400
629,568
666,826
679,107
785,265
830,069
862,624
930,337
931,932
1,007,440
1,103,942
1,417,975
1,544,195
1,638,597
1,607,347
1,639,443
2,374,301
2,302,582
2,306,012
2,397,157
2,519,947
2,645,762
2,754,161
2,947,633
3,214,818
3,426,750
2,752,422
3,212,321
3,307,430
3,560,918
3,661,436
3,904,623
4,198,831
4,933,352
5,054,221
5,319,035
5,510,214
5,840,984
5,797,623
6,208,259
6,388,239
6,782,107
6,782,1076,388,2396,208,2595,797,6235,840,9845,510,2145,319,0355,054,2214,933,3524,198,8313,904,6233,661,4363,560,9183,307,4303,212,3212,752,4223,426,7503,214,8182,947,6332,754,1612,645,7622,519,9472,397,1572,306,0122,302,5822,374,3011,639,4431,607,3471,638,5971,544,1951,417,9751,103,9421,007,440931,932930,337862,624830,069785,265679,107666,826629,568357,400334,219330,282330,419296,535311,971293,593328,962371,224416,663459,606489,581464,640493,681502,663712,390472,816159,016189,635232,388264,718204,735237,011275,695282,683308,798324,933353,603464,886375,112398,756374,108398,109436,647487,458516,919470,504538,118582,468379,545415,437470,475496,878552,139603,054645,736705,559705,559825,640852,068886,820886,820865,924876,635875,692221,900209,700224,200250,800230,300233,000219,200219,100193,100181,10076,60079,60066,90074,40066,00062,10057,80020,00023,00026,70028,70019,10013,30015,30017,6003,400
   > Total Current Assets 
1,700
15,700
13,400
10,600
16,200
25,300
22,400
17,700
12,100
49,000
50,300
47,800
53,900
43,200
49,800
43,800
133,500
138,200
152,200
147,200
137,600
131,400
149,000
117,400
98,900
109,500
728,940
711,108
684,574
647,895
647,895
592,470
592,915
591,221
591,221
527,520
489,309
458,771
401,906
378,553
337,834
310,927
514,119
483,395
420,843
481,313
457,492
407,858
370,821
353,976
329,179
296,167
432,001
327,761
300,422
288,312
270,854
264,412
227,595
194,055
257,024
205,494
165,365
146,718
402,657
656,055
450,807
451,293
422,545
455,454
425,968
391,923
346,418
310,778
276,162
294,158
278,728
309,514
309,113
313,369
333,743
555,799
581,170
577,145
662,614
699,214
692,145
732,990
757,914
866,848
935,581
792,130
886,660
993,602
819,175
844,803
1,541,322
1,501,521
1,469,555
1,598,084
1,700,359
1,855,855
1,930,069
2,058,625
2,365,171
2,537,047
1,716,169
2,077,625
2,159,425
2,422,657
2,514,105
2,620,060
2,923,797
3,186,732
3,356,598
3,690,127
3,821,111
4,198,947
4,110,758
4,264,433
4,627,423
4,645,402
4,645,4024,627,4234,264,4334,110,7584,198,9473,821,1113,690,1273,356,5983,186,7322,923,7972,620,0602,514,1052,422,6572,159,4252,077,6251,716,1692,537,0472,365,1712,058,6251,930,0691,855,8551,700,3591,598,0841,469,5551,501,5211,541,322844,803819,175993,602886,660792,130935,581866,848757,914732,990692,145699,214662,614577,145581,170555,799333,743313,369309,113309,514278,728294,158276,162310,778346,418391,923425,968455,454422,545451,293450,807656,055402,657146,718165,365205,494257,024194,055227,595264,412270,854288,312300,422327,761432,001296,167329,179353,976370,821407,858457,492481,313420,843483,395514,119310,927337,834378,553401,906458,771489,309527,520591,221591,221592,915592,470647,895647,895684,574711,108728,940109,50098,900117,400149,000131,400137,600147,200152,200138,200133,50043,80049,80043,20053,90047,80050,30049,00012,10017,70022,40025,30016,20010,60013,40015,7001,700
       Cash And Cash Equivalents 
1,700
15,500
13,300
10,500
4,300
6,800
5,900
7,400
5,700
10,400
12,500
7,200
19,700
7,600
8,000
11,300
51,300
51,200
42,700
32,900
45,400
50,000
83,500
53,300
41,400
32,200
421,334
438,113
328,377
110,155
110,155
64,395
45,488
43,368
43,368
44,193
15,736
22,928
10,637
22,015
14,307
29,698
135,847
152,933
78,724
132,180
104,836
37,177
49,197
11,494
48,804
35,938
115,921
18,861
20,298
33,935
95,629
108,854
162,741
134,712
207,597
178,767
139,098
114,289
367,478
449,824
404,746
414,088
388,804
417,912
377,843
359,074
312,328
273,164
231,855
261,807
239,083
224,057
265,814
258,202
272,122
471,429
436,585
406,264
382,004
452,297
421,822
439,681
445,801
521,439
657,615
487,654
580,099
652,343
361,823
451,754
1,128,046
899,509
894,427
928,517
1,112,179
1,163,980
1,299,704
1,416,224
1,702,023
1,832,684
1,043,241
1,326,730
1,497,775
1,513,008
1,669,968
1,797,582
1,999,021
2,057,440
2,256,759
2,435,381
2,690,622
2,951,422
2,821,051
3,131,123
3,227,230
3,213,376
3,213,3763,227,2303,131,1232,821,0512,951,4222,690,6222,435,3812,256,7592,057,4401,999,0211,797,5821,669,9681,513,0081,497,7751,326,7301,043,2411,832,6841,702,0231,416,2241,299,7041,163,9801,112,179928,517894,427899,5091,128,046451,754361,823652,343580,099487,654657,615521,439445,801439,681421,822452,297382,004406,264436,585471,429272,122258,202265,814224,057239,083261,807231,855273,164312,328359,074377,843417,912388,804414,088404,746449,824367,478114,289139,098178,767207,597134,712162,741108,85495,62933,93520,29818,861115,92135,93848,80411,49449,19737,177104,836132,18078,724152,933135,84729,69814,30722,01510,63722,92815,73644,19343,36843,36845,48864,395110,155110,155328,377438,113421,33432,20041,40053,30083,50050,00045,40032,90042,70051,20051,30011,3008,0007,60019,7007,20012,50010,4005,7007,4005,9006,8004,30010,50013,30015,5001,700
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40,700
34,700
270,820
242,805
316,255
472,025
472,025
475,006
472,058
464,535
464,535
431,958
437,093
406,090
365,547
338,624
300,791
264,109
364,860
320,622
333,838
337,584
343,858
364,272
314,841
333,477
272,695
253,808
310,380
299,712
273,480
247,533
169,315
147,576
56,372
51,309
42,264
19,257
18,591
26,186
20,767
20,594
17,494
8,102
6,781
6,256
5,783
5,036
4,647
4,430
4,556
4,244
4,516
4,361
4,365
19,251
19,052
37,575
82,646
102,489
150,355
147,966
163,602
187,788
189,244
186,344
153,054
141,537
136,486
156,203
150,132
156,852
153,343
270,136
276,632
269,865
263,134
274,343
281,320
279,631
284,195
284,870
259,351
262,756
237,025
288,369
292,425
283,385
285,054
290,752
287,401
287,044
286,500
287,543
291,661
292,243
289,223
442,667
442,667289,223292,243291,661287,543286,500287,044287,401290,752285,054283,385292,425288,369237,025262,756259,351284,870284,195279,631281,320274,343263,134269,865276,632270,136153,343156,852150,132156,203136,486141,537153,054186,344189,244187,788163,602147,966150,355102,48982,64637,57519,05219,2514,3654,3614,5164,2444,5564,4304,6475,0365,7836,2566,7818,10217,49420,59420,76726,18618,59119,25742,26451,30956,372147,576169,315247,533273,480299,712310,380253,808272,695333,477314,841364,272343,858337,584333,838320,622364,860264,109300,791338,624365,547406,090437,093431,958464,535464,535472,058475,006472,025472,025316,255242,805270,82034,70040,700000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
400
600
100
7,200
100
9,400
3,000
2,500
8,700
4,000
9,300
19,900
8,600
11,000
4,100
14,300
9,700
4,600
8,000
26,600
14,368
14,732
21,015
35,022
35,022
31,581
44,117
54,038
54,038
25,129
14,780
8,485
8,024
7,515
10,179
5,733
3,909
3,336
2,679
2,143
2,547
931
1,045
1,423
1,584
1,346
1,390
2,073
1,440
1,267
1,276
1,551
840
787
879
1,050
739
807
862
163,661
5,253
6,360
4,735
5,701
16,579
2,376
2,462
6,415
13,010
13,841
16,540
70,951
28,041
27,522
33,197
35,374
46,394
47,205
109,599
57,933
69,604
75,122
86,966
114,450
101,280
129,486
131,523
148,758
244,975
169,516
198,345
266,299
220,190
316,310
247,736
307,598
244,081
302,680
276,116
308,809
351,522
420,250
356,182
481,994
397,357
438,170
516,689
616,300
562,344
682,968
618,188
644,879
623,788
637,994
657,263
743,557
743,557657,263637,994623,788644,879618,188682,968562,344616,300516,689438,170397,357481,994356,182420,250351,522308,809276,116302,680244,081307,598247,736316,310220,190266,299198,345169,516244,975148,758131,523129,486101,280114,45086,96675,12269,60457,933109,59947,20546,39435,37433,19727,52228,04170,95116,54013,84113,0106,4152,4622,37616,5795,7014,7356,3605,253163,6618628077391,0508797878401,5511,2761,2671,4402,0731,3901,3461,5841,4231,0459312,5472,1432,6793,3363,9095,73310,1797,5158,0248,48514,78025,12954,03854,03844,11731,58135,02235,02221,01514,73214,36826,6008,0004,6009,70014,3004,10011,0008,60019,9009,3004,0008,7002,5003,0009,4001007,200100600400000000
       Other Current Assets 
0
200
100
100
11,900
18,500
16,100
9,700
6,300
31,400
37,700
31,200
31,200
33,100
33,100
28,500
72,900
67,100
100,900
103,300
88,100
67,100
55,800
59,500
8,800
16,000
22,418
15,458
18,927
30,693
30,693
21,488
31,252
29,280
29,280
26,240
21,700
21,268
17,698
10,399
12,557
11,387
9,503
6,504
5,602
2,264
6,251
5,478
5,738
7,582
6,096
5,075
4,310
7,115
5,204
5,577
4,634
6,431
7,642
7,247
6,284
6,420
6,937
5,436
13,550
21,976
23,314
22,743
22,225
25,585
25,763
25,437
26,981
26,769
26,741
18,322
18,399
9,867
10,704
8,261
9,013
11,015
15,198
20,918
20,254
40,660
34,703
28,502
33,475
18,359
22,323
27,329
34,474
32,768
58,284
63,751
58,327
62,428
73,674
77,523
71,317
79,366
72,266
53,563
49,896
43,725
48,078
51,554
51,431
60,098
73,519
84,248
101,730
126,278
146,130
165,950
179,932
167,011
216,694
167,136
254,421
182,830
182,830254,421167,136216,694167,011179,932165,950146,130126,278101,73084,24873,51960,09851,43151,55448,07843,72549,89653,56372,26679,36671,31777,52373,67462,42858,32763,75158,28432,76834,47427,32922,32318,35933,47528,50234,70340,66020,25420,91815,19811,0159,0138,26110,7049,86718,39918,32226,74126,76926,98125,43725,76325,58522,22522,74323,31421,97613,5505,4366,9376,4206,2847,2477,6426,4314,6345,5775,2047,1154,3105,0756,0967,5825,7385,4786,2512,2645,6026,5049,50311,38712,55710,39917,69821,26821,70026,24029,28029,28031,25221,48830,69330,69318,92715,45822,41816,0008,80059,50055,80067,10088,100103,300100,90067,10072,90028,50033,10033,10031,20031,20037,70031,4006,3009,70016,10018,50011,9001001002000
   > Long-term Assets 
1,700
1,900
1,900
2,700
2,900
3,400
4,300
5,300
7,900
8,800
11,800
18,200
20,500
23,700
29,800
32,800
47,600
54,900
66,900
72,000
95,400
98,900
101,800
106,800
110,800
112,400
146,752
165,527
181,350
238,925
238,925
259,598
232,725
114,338
114,338
118,216
113,745
93,368
94,972
91,922
77,603
68,618
68,349
54,723
49,661
35,606
29,966
28,789
27,288
20,132
69,577
78,945
32,885
25,842
24,511
20,486
11,829
11,283
9,416
10,680
7,694
26,894
24,270
12,298
70,159
56,335
51,856
42,388
42,095
34,127
33,638
24,740
24,806
18,184
17,431
17,813
17,807
20,905
21,169
20,850
23,657
73,769
85,656
101,962
122,651
130,855
170,479
197,347
174,018
140,592
168,361
625,845
657,535
644,995
788,172
794,640
832,979
801,061
836,457
799,073
819,588
789,907
824,092
889,008
849,647
889,703
1,036,253
1,134,696
1,148,005
1,138,261
1,147,331
1,284,563
1,275,034
1,746,620
1,697,623
1,628,908
1,689,103
1,642,037
1,686,865
1,943,826
1,760,816
2,136,705
2,136,7051,760,8161,943,8261,686,8651,642,0371,689,1031,628,9081,697,6231,746,6201,275,0341,284,5631,147,3311,138,2611,148,0051,134,6961,036,253889,703849,647889,008824,092789,907819,588799,073836,457801,061832,979794,640788,172644,995657,535625,845168,361140,592174,018197,347170,479130,855122,651101,96285,65673,76923,65720,85021,16920,90517,80717,81317,43118,18424,80624,74033,63834,12742,09542,38851,85656,33570,15912,29824,27026,8947,69410,6809,41611,28311,82920,48624,51125,84232,88578,94569,57720,13227,28828,78929,96635,60649,66154,72368,34968,61877,60391,92294,97293,368113,745118,216114,338114,338232,725259,598238,925238,925181,350165,527146,752112,400110,800106,800101,80098,90095,40072,00066,90054,90047,60032,80029,80023,70020,50018,20011,8008,8007,9005,3004,3003,4002,9002,7001,9001,9001,700
       Property Plant Equipment 
1,500
1,900
1,900
2,700
2,800
3,300
4,300
5,200
7,800
8,700
11,400
17,800
20,000
22,900
25,300
25,800
30,200
36,900
43,400
45,700
50,300
54,400
58,600
64,000
66,600
67,300
73,562
87,930
96,285
98,948
98,948
92,163
80,194
47,927
47,927
45,264
44,422
31,787
33,789
32,021
30,786
27,337
22,846
11,535
10,511
9,959
9,011
8,883
8,119
7,667
6,837
6,253
5,741
5,890
5,197
4,539
3,874
3,943
3,501
3,110
2,825
2,796
2,495
2,189
1,981
1,752
1,808
2,159
2,385
4,804
4,934
5,500
6,077
6,431
6,232
6,515
6,169
6,348
6,485
6,236
6,201
26,848
38,654
55,607
75,258
81,790
80,667
81,602
83,186
86,006
92,622
138,513
151,942
167,679
193,211
218,878
246,825
259,763
264,610
267,586
300,767
319,751
338,331
369,470
376,940
406,625
438,656
481,910
527,458
588,076
622,657
689,043
713,851
751,468
756,609
748,677
742,412
765,608
767,550
774,983
757,926
777,048
777,048757,926774,983767,550765,608742,412748,677756,609751,468713,851689,043622,657588,076527,458481,910438,656406,625376,940369,470338,331319,751300,767267,586264,610259,763246,825218,878193,211167,679151,942138,51392,62286,00683,18681,60280,66781,79075,25855,60738,65426,8486,2016,2366,4856,3486,1696,5156,2326,4316,0775,5004,9344,8042,3852,1591,8081,7521,9812,1892,4952,7962,8253,1103,5013,9433,8744,5395,1975,8905,7416,2536,8377,6678,1198,8839,0119,95910,51111,53522,84627,33730,78632,02133,78931,78744,42245,26447,92747,92780,19492,16398,94898,94896,28587,93073,56267,30066,60064,00058,60054,40050,30045,70043,40036,90030,20025,80025,30022,90020,00017,80011,4008,7007,8005,2004,3003,3002,8002,7001,9001,9001,500
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
155,725
155,702
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593
155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,593155,702155,7250000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,829
67,003
35,714
35,248
32,298
31,444
55,745
31,987
158,322
144,425
169,020
134,356
165,972
131,330
121,381
99,199
120,188
115,563
117,902
133,657
180,993
248,731
222,810
222,301
202,174
220,691
192,096
221,266
174,681
149,784
149,124
133,676
128,313
170,316
153,663
187,716
187,716153,663170,316128,313133,676149,124149,784174,681221,266192,096220,691202,174222,301222,810248,731180,993133,657117,902115,563120,18899,199121,381131,330165,972134,356169,020144,425158,32231,98755,74531,44432,29835,24835,71467,00339,82900000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,600
17,000
16,400
15,800
15,200
14,600
13,966
13,369
12,771
82,944
82,944
76,961
73,970
2,914
2,914
27,262
24,679
26,066
27,434
28,543
28,609
25,085
32,231
30,030
27,395
14,220
13,607
12,519
11,783
11,097
10,408
9,785
9,354
8,715
8,204
7,610
7,038
406
5,876
5,559
4,837
4,339
3,837
3,099
14,641
13,879
13,879
0
0
10,432
9,793
0
0
8,217
7,686
7,154
6,620
6,082
5,543
3,204
2,508
17,484
17,125
16,514
15,739
15,987
19,087
15,938
19,169
12,279
12,298
281,205
275,821
270,437
265,053
259,669
242,285
236,901
231,517
226,132
220,748
215,364
209,980
204,596
199,212
193,828
188,444
183,060
177,675
172,291
166,907
161,523
156,139
150,755
145,371
139,987
134,603
129,219
140,658
134,954
129,249
123,545
123,545129,249134,954140,658129,219134,603139,987145,371150,755156,139161,523166,907172,291177,675183,060188,444193,828199,212204,596209,980215,364220,748226,132231,517236,901242,285259,669265,053270,437275,821281,20512,29812,27919,16915,93819,08715,98715,73916,51417,12517,4842,5083,2045,5436,0826,6207,1547,6868,217009,79310,4320013,87913,87914,6413,0993,8374,3394,8375,5595,8764067,0387,6108,2048,7159,3549,78510,40811,09711,78312,51913,60714,22027,39530,03032,23125,08528,60928,54327,43426,06624,67927,2622,9142,91473,97076,96182,94482,94412,77113,36913,96614,60015,20015,80016,40017,00017,60000000000000000000000
       Long-term Assets Other 
200
0
0
0
100
100
0
100
100
100
400
400
500
800
4,500
7,000
17,400
18,000
23,500
26,300
27,500
27,500
26,800
27,000
29,000
30,500
59,224
64,228
72,294
57,033
57,033
90,474
78,561
63,497
63,497
45,690
44,644
35,515
33,749
31,358
18,208
16,196
13,272
13,158
11,755
11,427
7,348
7,387
7,386
1,368
52,332
62,907
17,790
11,237
11,110
8,337
917
6,934
39
2,011
32
19,759
17,938
7,010
46,623
37,191
50,034
40,229
39,710
18,891
18,911
19,240
18,729
3,536
3,513
4,144
5,018
8,475
9,141
11,410
14,948
29,837
47,002
46,355
47,393
49,065
49,983
48,742
55,118
19,338
43,441
18,958
18,325
19,299
15,993
16,075
19,256
14,448
18,765
18,432
21,099
23,601
25,569
43,786
45,576
55,559
72,567
65,402
64,469
62,763
64,136
57,713
57,355
68,058
68,507
64,282
80,531
106,097
4,500
175,473
224,758
260,917
260,917224,758175,4734,500106,09780,53164,28268,50768,05857,35557,71364,13662,76364,46965,40272,56755,55945,57643,78625,56923,60121,09918,43218,76514,44819,25616,07515,99319,29918,32518,95843,44119,33855,11848,74249,98349,06547,39346,35547,00229,83714,94811,4109,1418,4755,0184,1443,5133,53618,72919,24018,91118,89139,71040,22950,03437,19146,6237,01017,93819,759322,011396,9349178,33711,11011,23717,79062,90752,3321,3687,3867,3877,34811,42711,75513,15813,27216,19618,20831,35833,74935,51544,64445,69063,49763,49778,56190,47457,03357,03372,29464,22859,22430,50029,00027,00026,80027,50027,50026,30023,50018,00017,4007,0004,5008005004004001001001000100100000200
> Total Liabilities 
1,100
1,500
1,300
1,700
1,500
4,700
4,700
3,800
3,600
11,000
17,200
22,600
29,900
21,700
33,300
27,100
40,000
47,100
67,800
61,300
57,300
50,700
73,200
53,300
44,100
51,600
271,372
274,694
256,438
264,126
264,126
247,776
242,203
265,356
265,356
241,464
232,572
249,729
232,869
233,119
221,372
225,212
464,650
485,486
439,744
438,402
427,590
402,896
394,594
393,505
436,527
429,837
531,036
438,511
429,410
428,433
424,156
435,212
434,059
441,930
442,095
453,138
446,386
450,446
672,172
814,774
617,076
598,464
593,548
578,225
563,584
552,947
552,244
556,039
542,450
529,159
516,485
330,419
493,808
362,005
328,609
629,568
666,826
850,105
874,856
830,069
904,037
875,163
843,195
836,285
876,194
1,120,912
1,174,209
1,219,130
641,413
612,608
616,551
671,953
677,968
664,234
717,048
719,795
668,594
700,442
792,291
828,344
814,701
867,717
916,597
949,650
933,592
968,762
1,050,174
1,163,348
1,191,149
1,233,974
1,283,563
1,470,865
1,335,055
1,467,567
1,456,792
1,592,270
1,592,2701,456,7921,467,5671,335,0551,470,8651,283,5631,233,9741,191,1491,163,3481,050,174968,762933,592949,650916,597867,717814,701828,344792,291700,442668,594719,795717,048664,234677,968671,953616,551612,608641,4131,219,1301,174,2091,120,912876,194836,285843,195875,163904,037830,069874,856850,105666,826629,568328,609362,005493,808330,419516,485529,159542,450556,039552,244552,947563,584578,225593,548598,464617,076814,774672,172450,446446,386453,138442,095441,930434,059435,212424,156428,433429,410438,511531,036429,837436,527393,505394,594402,896427,590438,402439,744485,486464,650225,212221,372233,119232,869249,729232,572241,464265,356265,356242,203247,776264,126264,126256,438274,694271,37251,60044,10053,30073,20050,70057,30061,30067,80047,10040,00027,10033,30021,70029,90022,60017,20011,0003,6003,8004,7004,7001,5001,7001,3001,5001,100
   > Total Current Liabilities 
700
1,000
900
1,000
1,000
4,600
4,600
3,700
3,600
10,400
16,700
22,100
29,300
21,100
32,900
26,700
39,500
46,600
66,700
60,400
55,700
49,900
72,600
52,900
43,800
51,500
67,949
71,402
53,271
76,312
76,312
68,307
62,845
86,108
86,108
69,214
60,429
77,693
60,939
61,296
53,482
57,426
46,968
67,908
60,898
31,481
21,640
27,033
27,284
27,857
140,342
140,951
136,793
49,340
39,650
38,192
33,214
36,595
34,304
41,651
40,820
50,337
42,098
45,621
44,276
132,826
117,944
110,944
117,522
113,573
110,182
110,667
120,957
135,614
142,299
139,731
137,641
136,074
121,283
102,958
109,498
108,042
106,944
112,547
124,660
221,515
225,595
192,472
155,823
836,285
200,319
198,986
240,545
1,219,130
304,716
293,161
319,935
360,952
381,072
368,239
422,489
415,360
363,947
367,105
492,211
500,462
503,412
556,513
606,202
648,793
636,121
660,324
742,712
885,081
914,968
962,781
1,006,596
1,216,603
1,084,207
1,118,773
1,217,869
1,240,379
1,240,3791,217,8691,118,7731,084,2071,216,6031,006,596962,781914,968885,081742,712660,324636,121648,793606,202556,513503,412500,462492,211367,105363,947415,360422,489368,239381,072360,952319,935293,161304,7161,219,130240,545198,986200,319836,285155,823192,472225,595221,515124,660112,547106,944108,042109,498102,958121,283136,074137,641139,731142,299135,614120,957110,667110,182113,573117,522110,944117,944132,82644,27645,62142,09850,33740,82041,65134,30436,59533,21438,19239,65049,340136,793140,951140,34227,85727,28427,03321,64031,48160,89867,90846,96857,42653,48261,29660,93977,69360,42969,21486,10886,10862,84568,30776,31276,31253,27171,40267,94951,50043,80052,90072,60049,90055,70060,40066,70046,60039,50026,70032,90021,10029,30022,10016,70010,4003,6003,7004,6004,6001,0001,0009001,000700
       Short-term Debt 
200
300
300
500
300
100
100
100
100
100
100
100
100
100
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,873
18,042
0
20,533
38,864
19,831
19,399
0
0
52,298
51,430
18,587
14,825
16,546
20,235
18,096
91,804
91,747
91,690
15,873
15,694
16,330
19,040
22,867
19,246
22,845
25,565
29,323
0
0
0
0
0
0
0
0
0
0
0
0
9,546
9,680
9,816
0
0
0
0
0
0
0
0
85,640
87,337
42,940
5
619,893
0
134,491
162,299
651,481
41,604
23,428
23,711
7,393
7,460
7,554
7,648
18,696
10,245
791
11,135
28,307
28,455
29,836
24,591
14,958
13,976
13,403
12,249
13,189
12,700
12,405
11,604
11,374
3,149
10,250
3,064
9,125
9,1253,06410,2503,14911,37411,60412,40512,70013,18912,24913,40313,97614,95824,59129,83628,45528,30711,13579110,24518,6967,6487,5547,4607,39323,71123,42841,604651,481162,299134,4910619,893542,94087,33785,640000000009,8169,6809,54600000000000029,32325,56522,84519,24622,86719,04016,33015,69415,87391,69091,74791,80418,09620,23516,54614,82518,58751,43052,2980019,39919,83138,86420,533018,04211,8730000000000000000000100100100100100100100100100100300500300300200
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
85,186
0
0
0
619,893
0
0
0
651,481
41,604
23,428
23,711
7,393
7,460
7,554
7,648
0
10,245
0
0
18,300
18,524
18,588
11,900
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000011,90018,58818,52418,3000010,24507,6487,5547,4607,39323,71123,42841,604651,481000619,89300085,1860000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
400
500
500
400
500
1,500
1,700
1,200
900
2,200
2,300
5,000
4,300
4,700
4,000
3,600
4,400
5,500
6,700
3,500
5,700
8,200
6,500
4,600
6,100
6,500
11,903
13,547
11,848
17,497
17,497
8,428
8,212
7,347
7,347
8,447
7,216
9,073
7,466
5,416
7,157
6,450
5,490
5,010
2,950
2,321
2,322
4,183
4,372
3,573
5,909
5,377
3,704
5,916
4,511
4,959
6,421
7,806
13,228
13,481
13,465
15,679
15,084
15,840
14,176
20,964
13,304
9,158
7,750
10,773
7,791
8,788
11,038
14,939
13,174
11,102
12,764
13,961
15,515
13,471
18,212
19,102
17,950
27,251
26,605
24,462
26,586
29,162
27,366
30,085
31,899
40,724
57,524
75,599
86,327
69,093
69,933
67,671
74,115
75,559
95,478
103,827
70,363
66,184
95,376
83,647
60,937
90,909
122,512
98,767
85,058
122,100
114,509
172,110
152,547
194,770
163,175
277,546
55,633
155,538
1,217,869
109,601
109,6011,217,869155,53855,633277,546163,175194,770152,547172,110114,509122,10085,05898,767122,51290,90960,93783,64795,37666,18470,363103,82795,47875,55974,11567,67169,93369,09386,32775,59957,52440,72431,89930,08527,36629,16226,58624,46226,60527,25117,95019,10218,21213,47115,51513,96112,76411,10213,17414,93911,0388,7887,79110,7737,7509,15813,30420,96414,17615,84015,08415,67913,46513,48113,2287,8066,4214,9594,5115,9163,7045,3775,9093,5734,3724,1832,3222,3212,9505,0105,4906,4507,1575,4167,4669,0737,2168,4477,3477,3478,2128,42817,49717,49711,84813,54711,9036,5006,1004,6006,5008,2005,7003,5006,7005,5004,4003,6004,0004,7004,3005,0002,3002,2009001,2001,7001,500500400500500400
       Other Current Liabilities 
100
200
100
100
200
3,000
2,800
2,400
2,600
8,100
14,300
17,000
24,900
16,300
28,900
23,100
35,100
41,100
60,000
56,900
50,000
41,700
66,100
48,300
37,700
45,000
56,046
57,855
41,423
58,815
58,815
40,142
35,745
78,761
42,843
25,868
37,697
36,425
1,561
20,978
18,004
44,575
37,448
7,077
2,346
8,766
2,268
5,553
1,935
5,584
19,632
20,893
18,464
4,668
1,758
5,273
1,758
5,273
1,758
5,273
1,758
5,273
26,942
29,729
30,068
44,832
37,620
34,786
42,792
35,827
35,413
34,903
42,946
51,372
46,596
42,980
48,088
56,034
53,214
50,458
65,783
76,050
76,107
72,411
85,173
98,533
98,815
107,513
115,595
173,795
159,123
17,688
17,854
301,000
218,389
224,068
250,002
26,848
28,175
29,501
29,665
66,412
293,584
83,327
88,708
76,064
95,550
109,469
88,607
86,211
116,588
98,922
112,872
82,760
749,721
320,739
404,977
469,742
1,025,425
123,781
982,205
111,747
111,747982,205123,7811,025,425469,742404,977320,739749,72182,760112,87298,922116,58886,21188,607109,46995,55076,06488,70883,327293,58466,41229,66529,50128,17526,848250,002224,068218,389301,00017,85417,688159,123173,795115,595107,51398,81598,53385,17372,41176,10776,05065,78350,45853,21456,03448,08842,98046,59651,37242,94634,90335,41335,82742,79234,78637,62044,83230,06829,72926,9425,2731,7585,2731,7585,2731,7585,2731,7584,66818,46420,89319,6325,5841,9355,5532,2688,7662,3467,07737,44844,57518,00420,9781,56136,42537,69725,86842,84378,76135,74540,14258,81558,81541,42357,85556,04645,00037,70048,30066,10041,70050,00056,90060,00041,10035,10023,10028,90016,30024,90017,00014,3008,1002,6002,4002,8003,000200100100200100
   > Long-term Liabilities 
400
500
400
700
500
100
100
100
100
600
500
500
600
600
400
400
500
500
1,100
900
1,600
800
600
400
300
100
203,423
203,292
203,167
187,814
187,814
179,469
179,358
179,248
179,248
172,250
172,143
172,036
171,930
171,823
167,890
167,786
417,682
417,578
378,846
406,921
405,950
375,863
367,310
365,648
296,185
288,886
394,243
389,171
389,760
390,241
390,942
398,617
399,755
400,279
401,275
402,801
404,288
404,825
627,896
681,948
499,132
487,520
476,026
464,652
453,402
442,280
431,287
420,425
400,151
389,428
378,844
369,302
372,525
259,047
219,111
714,634
722,304
737,558
750,196
690,182
678,442
682,691
687,372
668,278
675,875
921,926
933,664
945,629
336,697
319,447
296,616
311,001
296,896
295,995
294,559
304,435
304,647
333,337
300,080
327,882
311,289
311,204
310,395
300,857
297,471
308,438
307,462
278,267
276,181
271,193
276,967
254,262
250,848
348,794
238,923
351,891
351,891238,923348,794250,848254,262276,967271,193276,181278,267307,462308,438297,471300,857310,395311,204311,289327,882300,080333,337304,647304,435294,559295,995296,896311,001296,616319,447336,697945,629933,664921,926675,875668,278687,372682,691678,442690,182750,196737,558722,304714,634219,111259,047372,525369,302378,844389,428400,151420,425431,287442,280453,402464,652476,026487,520499,132681,948627,896404,825404,288402,801401,275400,279399,755398,617390,942390,241389,760389,171394,243288,886296,185365,648367,310375,863405,950406,921378,846417,578417,682167,786167,890171,823171,930172,036172,143172,250179,248179,248179,358179,469187,814187,814203,167203,292203,4231003004006008001,6009001,100500500400400600600500500600100100100100500700400500400
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
298,919
304,534
310,277
316,153
312,616
318,630
324,783
331,076
337,513
223,817
187,136
661,567
665,222
673,315
681,313
603,478
610,210
617,025
623,928
619,893
627,642
635,491
643,434
651,481
41,604
23,428
23,711
16,608
16,811
17,016
17,224
17,434
17,647
17,862
18,080
31,918
31,959
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000031,95931,91818,08017,86217,64717,43417,22417,01616,81116,60823,71123,42841,604651,481643,434635,491627,642619,893623,928617,025610,210603,478681,313673,315665,222661,567187,136223,817337,513331,076324,783318,630312,616316,153310,277304,534298,9190000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,155
27,264
26,357
25,391
23,786
39,355
31,960
25,201
18,068
16,561
14,908
13,439
12,061
10,858
9,000
7,573
6,634
5,614
3,600
2,372
238,810
221,432
204,695
187,958
171,220
154,483
137,746
121,010
104,272
87,535
70,798
54,061
38,226
35,012
35,230
31,975
52,172
56,190
63,343
68,108
67,063
62,207
57,941
53,732
48,385
48,233
286,435
290,230
294,148
295,093
296,019
272,905
279,949
280,085
278,979
277,335
277,084
273,080
270,548
267,470
271,232
268,179
265,331
264,123
266,000
263,000
259,000
252,000
244,000
273,601
276,143
206,000
269,596
299,245
0
0
0
000299,245269,596206,000276,143273,601244,000252,000259,000263,000266,000264,123265,331268,179271,232267,470270,548273,080277,084277,335278,979280,085279,949272,905296,019295,093294,148290,230286,43548,23348,38553,73257,94162,20767,06368,10863,34356,19052,17231,97535,23035,01238,22654,06170,79887,535104,272121,010137,746154,483171,220187,958204,695221,432238,8102,3723,6005,6146,6347,5739,00010,85812,06113,43914,90816,56118,06825,20131,96039,35523,78625,39126,35727,26428,155000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
154,483
137,746
121,010
104,272
87,535
70,798
54,061
38,226
35,012
31,797
28,583
26,264
23,046
19,840
16,501
32,152
15,322
13,808
12,581
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000012,58113,80815,32232,15216,50119,84023,04626,26428,58331,79735,01238,22654,06170,79887,535104,272121,010137,746154,4830000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
2,300
16,100
14,000
11,600
17,600
24,000
22,000
19,200
16,400
46,800
44,900
43,400
44,500
45,200
46,300
49,500
141,100
146,000
151,300
157,900
175,700
179,600
177,600
170,900
165,600
170,300
604,320
601,941
609,486
622,694
622,694
604,292
583,437
440,203
440,203
404,272
370,482
302,410
264,009
237,356
194,065
154,333
117,818
52,632
30,760
78,517
59,868
33,751
3,515
-19,397
-37,771
-54,725
-66,150
-84,908
-104,477
-119,635
-141,473
-159,517
-197,048
-237,195
-177,377
-220,750
-256,751
-291,430
-199,356
-102,384
-114,413
-104,783
-128,908
-88,644
-103,978
-136,284
-181,020
-227,077
-248,857
-217,188
-219,950
-174,957
-163,526
-27,786
28,791
-193,108
-162,422
-170,998
-89,591
-81,628
-41,413
55,174
88,737
171,155
227,748
297,063
369,986
419,467
965,934
1,026,835
1,757,750
1,630,629
1,628,044
1,732,923
1,802,899
1,925,967
2,085,567
2,247,191
2,422,527
2,598,406
1,937,721
2,344,604
2,390,833
2,611,268
2,727,844
2,935,861
3,148,657
3,770,004
3,863,072
4,085,061
4,226,651
4,370,119
4,462,568
4,740,692
4,931,447
5,189,837
5,189,8374,931,4474,740,6924,462,5684,370,1194,226,6514,085,0613,863,0723,770,0043,148,6572,935,8612,727,8442,611,2682,390,8332,344,6041,937,7212,598,4062,422,5272,247,1912,085,5671,925,9671,802,8991,732,9231,628,0441,630,6291,757,7501,026,835965,934419,467369,986297,063227,748171,15588,73755,174-41,413-81,628-89,591-170,998-162,422-193,10828,791-27,786-163,526-174,957-219,950-217,188-248,857-227,077-181,020-136,284-103,978-88,644-128,908-104,783-114,413-102,384-199,356-291,430-256,751-220,750-177,377-237,195-197,048-159,517-141,473-119,635-104,477-84,908-66,150-54,725-37,771-19,3973,51533,75159,86878,51730,76052,632117,818154,333194,065237,356264,009302,410370,482404,272440,203440,203583,437604,292622,694622,694609,486601,941604,320170,300165,600170,900177,600179,600175,700157,900151,300146,000141,10049,50046,30045,20044,50043,40044,90046,80016,40019,20022,00024,00017,60011,60014,00016,1002,300
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32
32
64
66
66
66
66
67
67
67
68
67
72
72
72
73
73
73
73
83
83
83
83
84
84
84
84
84
84
84
84
85
85
85
97
97
97
98
119
119
121
122
122
123
124
126
126
126
128
130
131
133
136
153
161
163
167
168
169
171
173
180
186
187
187
188
188
189
205
205
211
211
212
212
213
213
214
215
215
216
217
218
219
219
220
220
221
221
221
222
222
223
223
223
224
224
224224223223223222222221221221220220219219218217216215215214213213212212211211205205189188188187187186180173171169168167163161153136133131130128126126126124123122122121119119989797978585858484848484848484838383837373737372727267686767676666666664323200000000000000000000000000
   Retained Earnings Total Equity00-211,963-415,511-437,214-465,675-578,450-739,882-777,874-1,341,725-1,523,464-1,672,920-1,726,455-1,876,305-1,861,102-2,151,400-1,430,758-1,541,763-1,670,034-1,775,352-1,877,759-1,946,822-1,975,998-2,028,392-1,990,005-1,840,376-1,876,430-1,863,946-1,674,765-1,683,638-1,720,515-1,754,940-1,778,987-1,834,163-1,794,581-1,803,877-1,785,518-1,748,575-1,807,867-1,770,994-1,737,037-1,694,166-1,672,130-1,669,559-1,653,890-1,672,669-1,650,959-1,654,996-1,609,570-1,554,491-1,501,413-1,449,5420000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
-3,100
-3,100
-9,600
-9,600
-9,600
-9,600
-19,800
-11,900
-27,400
-31,300
-36,000
-41,100
-46,500
-1,000
2,600
25,761
26,537
34,213
-80,706
18,140
13,415
9,427
-87,505
863
-8,772
-4,774
-796
-818
-1,680
-1,400
-1,215
-824
-4,436
-1,468
-2,412
-842
-2,768
-2,880
1,228
-2,406
-1,809
521
-415
-143
-306
-356
-528
-1,766
-1,857
-3,363
-2,747
-2,072
-107
502
707
1,198
1,795
1,930
1,986
2,089
1,951
1,821
1,642
1,935
1,720
2,149
1,878
1,999
1,993
2,008
1,993
2,040
2,080
1,914
1,815
2,258
1,949
-275
-809
397
662
390
-2,886
5,377
10,968
12,512
-7,010
-10,122
-9,809
-9,522
-10,165
-9,247
-8,965
-8,614
-15,542
-13,107
-12,423
-9,748
-15,360
-20,358
-18,273
-18,646
-19,454
-23,047
-25,696
-29,062
15,069
20,942
26,806
22,894
13,106
13,10622,89426,80620,94215,069-29,062-25,696-23,047-19,454-18,646-18,273-20,358-15,360-9,748-12,423-13,107-15,542-8,614-8,965-9,247-10,165-9,522-9,809-10,122-7,01012,51210,9685,377-2,886390662397-809-2751,9492,2581,8151,9142,0802,0401,9932,0081,9931,9991,8782,1491,7201,9351,6421,8211,9512,0891,9861,9301,7951,198707502-107-2,072-2,747-3,363-1,857-1,766-528-356-306-143-415521-1,809-2,4061,228-2,880-2,768-842-2,412-1,468-4,436-824-1,215-1,400-1,680-818-796-4,774-8,772863-87,5059,42713,41518,140-80,70634,21326,53725,7612,600-1,000-46,500-41,100-36,000-31,300-27,400-11,900-19,800-9,600-9,600-9,600-9,600-3,100-3,10000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,343,351
1,363,052
1,371,524
1,380,725
1,404,076
1,431,921
1,450,439
1,476,922
1,503,898
1,642,198
1,720,788
1,541,773
1,606,365
1,634,621
1,656,901
1,701,904
1,760,033
1,847,626
1,922,989
1,950,764
1,982,104
2,016,728
2,053,046
2,096,929
2,824,298
2,892,092
3,585,403
3,627,433
3,666,346
3,718,518
3,759,030
3,813,678
3,869,952
3,925,975
3,972,689
4,044,490
4,102,011
4,217,911
4,276,667
4,352,864
4,420,902
4,477,378
4,508,807
4,567,111
4,625,780
4,688,985
4,721,166
4,792,041
4,856,914
4,925,626
0
0
004,925,6264,856,9144,792,0414,721,1664,688,9854,625,7804,567,1114,508,8074,477,3784,420,9024,352,8644,276,6674,217,9114,102,0114,044,4903,972,6893,925,9753,869,9523,813,6783,759,0303,718,5183,666,3463,627,4333,585,4032,892,0922,824,2982,096,9292,053,0462,016,7281,982,1041,950,7641,922,9891,847,6261,760,0331,701,9041,656,9011,634,6211,606,3651,541,7731,720,7881,642,1981,503,8981,476,9221,450,4391,431,9211,404,0761,380,7251,371,5241,363,0521,343,3510000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
24,600
24,600
24,700
33,800
44,000
43,900
44,000
44,200
76,900
77,100
80,300
84,300
91,300
91,400
92,700
181,300
191,900
191,500
208,400
236,900
244,000
249,000
255,100
215,400
222,900
726,144
736,847
759,770
0
788,238
805,606
787,012
0
795,780
703,326
795,451
708,163
725,563
726,672
726,113
726,962
727,771
729,797
730,933
817,150
817,062
818,016
818,103
818,638
821,204
824,173
826,255
828,936
831,242
834,686
837,392
841,320
845,184
850,692
956,798
961,214
964,574
967,964
1,102,765
1,287,974
1,311,181
1,317,169
1,324,611
1,332,277
1,343,351
1,363,052
1,371,524
1,380,725
1,404,076
1,431,921
1,450,439
1,476,922
1,503,898
1,642,198
1,720,788
1,541,773
1,606,365
1,634,621
1,656,901
1,701,904
1,760,033
1,847,626
1,922,989
1,950,764
1,982,104
2,016,728
2,053,046
2,096,929
2,824,298
2,892,092
3,585,403
3,627,433
3,666,346
3,718,518
3,759,030
3,813,678
3,869,952
3,925,975
3,972,689
4,044,490
4,102,011
4,217,911
4,276,667
4,352,864
4,420,902
4,477,378
4,508,807
4,567,111
4,625,780
4,688,985
4,721,166
4,792,041
4,856,914
4,925,626
4,949,023
5,016,122
5,016,1224,949,0234,925,6264,856,9144,792,0414,721,1664,688,9854,625,7804,567,1114,508,8074,477,3784,420,9024,352,8644,276,6674,217,9114,102,0114,044,4903,972,6893,925,9753,869,9523,813,6783,759,0303,718,5183,666,3463,627,4333,585,4032,892,0922,824,2982,096,9292,053,0462,016,7281,982,1041,950,7641,922,9891,847,6261,760,0331,701,9041,656,9011,634,6211,606,3651,541,7731,720,7881,642,1981,503,8981,476,9221,450,4391,431,9211,404,0761,380,7251,371,5241,363,0521,343,3511,332,2771,324,6111,317,1691,311,1811,287,9741,102,765967,964964,574961,214956,798850,692845,184841,320837,392834,686831,242828,936826,255824,173821,204818,638818,103818,016817,062817,150730,933729,797727,771726,962726,113726,672725,563708,163795,451703,326795,7800787,012805,606788,2380759,770736,847726,144222,900215,400255,100249,000244,000236,900208,400191,500191,900181,30092,70091,40091,30084,30080,30077,10076,90044,20044,00043,90044,00033,80024,70024,60024,6000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,695,649
Cost of Revenue-255,000
Gross Profit3,440,6493,440,649
 
Operating Income (+$)
Gross Profit3,440,649
Operating Expense-2,790,939
Operating Income620,525649,710
 
Operating Expense (+$)
Research Development1,627,594
Selling General Administrative1,161,300
Selling And Marketing Expenses0
Operating Expense2,790,9392,788,894
 
Net Interest Income (+$)
Interest Income172,348
Interest Expense-2,551
Other Finance Cost-63,594
Net Interest Income106,203
 
Pretax Income (+$)
Operating Income620,525
Net Interest Income106,203
Other Non-Operating Income Expenses0
Income Before Tax (EBT)834,215605,834
EBIT - interestExpense = 819,524
834,215
600,150
Interest Expense2,551
Earnings Before Interest and Taxes (EBIT)822,075836,766
Earnings Before Interest and Taxes (EBITDA)904,735
 
After tax Income (+$)
Income Before Tax834,215
Tax Provision-218,893
Net Income From Continuing Ops424,981615,322
Net Income597,599
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,045,939
Total Other Income/Expenses Net14,691-106,203
 

Technical Analysis of Incyte
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Incyte. The general trend of Incyte is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Incyte's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Incyte Corporation.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 51.47 < 52.20 < 56.10.

The bearish price targets are: 50.27.

Tweet this
Incyte Corporation Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Incyte Corporation. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Incyte Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Incyte Corporation. The current macd is -1.60268541.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Incyte price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Incyte. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Incyte price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Incyte Corporation Daily Moving Average Convergence/Divergence (MACD) ChartIncyte Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Incyte Corporation. The current adx is 34.09.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Incyte shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Incyte Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Incyte Corporation. The current sar is 53.56.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Incyte Corporation Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Incyte Corporation. The current rsi is 20.70. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Incyte Corporation Daily Relative Strength Index (RSI) ChartIncyte Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Incyte Corporation. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Incyte price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Incyte Corporation Daily Stochastic Oscillator ChartIncyte Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Incyte Corporation. The current cci is -132.7041145.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Incyte Corporation Daily Commodity Channel Index (CCI) ChartIncyte Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Incyte Corporation. The current cmo is -72.90126277.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Incyte Corporation Daily Chande Momentum Oscillator (CMO) ChartIncyte Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Incyte Corporation. The current willr is -86.4171263.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Incyte Corporation Daily Williams %R ChartIncyte Corporation Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Incyte Corporation.

Incyte Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Incyte Corporation. The current atr is 1.10166314.

Incyte Corporation Daily Average True Range (ATR) ChartIncyte Corporation Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Incyte Corporation. The current obv is -6,510,846.

Incyte Corporation Daily On-Balance Volume (OBV) ChartIncyte Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Incyte Corporation. The current mfi is 13.46.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Incyte Corporation Daily Money Flow Index (MFI) ChartIncyte Corporation Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Incyte Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Incyte Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Incyte Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5020.704
Ma 20Greater thanMa 5054.007
Ma 50Greater thanMa 10056.943
Ma 100Greater thanMa 20058.816
OpenGreater thanClose51.580
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Incyte with someone you think should read this too:
  • Are you bullish or bearish on Incyte? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Incyte? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Incyte Corporation

I send you an email if I find something interesting about Incyte Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about Incyte Corporation.

Receive notifications about Incyte Corporation in your mailbox!